Healthcare
EQT exits Roeser after seven-year holding period
PE house sells the German distributor of medical supplies to private hospital firm Sana Kliniken
Ysios, Omega lead €15m series-A for Anaconda Biomed
Additional backers include Banco Sabadell and existing investor Innogest Capital
BC Partners buys DentalPro from Summit
Deal is the second transaction for the GP's 10th buyout vehicle, BC European Capital X
M Capital, Normandie Participations lead €4.7m Robocath round
Backers are joined in the round by previous investors Go Capital and NCI Gestion
Vesalius Biocapital holds €65m first close for third fund
Vesalius Biocapital III will accept new investors on a "rolling closing" basis until final close
Vendis Capital invests in Sylphar
Transaction marks the sixth investment made from Vendis Capital II, closed on €180m in May last year
LSP leads €15m series-A for Cardior Pharmaceuticals
New funding will allow the company to develop its lead compound, which targets RNAs linked to heart failure
HTGF et al. invest in Numaferm
European Investment Fund and angel investors also participated in the seed funding round
PAI enters exclusivity with Ergon for EliTech SBO
Ergon bought the medical equipment maker in 2010 in a deal valued at more than €100m
Gimv acquires stake in MVZ Holding
Gimv will provide financial and strategic support for MVZ Holding’s growth and acquisition strategy
Apposite Capital leads €7m round for NIMGenetics
Deal is the third acquisition for the GP's 2016-vintage vehicle, Apposite Healthcare Fund II
EMBL and Life Sciences Partners sell Luxendo to Bruker
Bruker will expand its portfolio with the addition of Luxendo's microscopes and intellectual property
Novartis, Columbus et al. in €37.5m series-A round for Vivet
Other investors in the round include Roche Venture Fund, HealthCap, Kurma Partners and Ysios Capital
BIVF at al. lead €20m series-A for ImCheck Therapeutics
Backers include Kurma Partners, Idinvest, Gimv and Life Sciences Partners
Shot in the arm for DACH healthcare market
Consolidation opportunities in the mid-market fuel increased investment from private equity, with aggregate volume reaching a six-year high
Eurazeo sells Colisée to IK Investment Partners
Sale follows a three-year tenure and reportedly values the care home operator at €236m
B&M Gates and VCs hold $45.5m series-D for Arsanis
New funding will be used to focus efforts on a phase II study for the prevention of pneumonia
Bain and Cinven publish Stada offer document
Offer values company at €5.3bn, the largest PE-backed takeover bid ever launched in Germany
HTGF and IFH back KSK Diagnostics
New funding will be used to develop point-of-care tests by utilising isothermal amplification technology
AGIC acquires laser manufacturer Fotona
Fotona will use the new funding and local support from AGIC to expand its sales effort in Asia
Advent France Biotechnology holds €64.75m first close
Firm was launched in 2016 and targets early-stage companies in the life sciences sector
BC's Elysium acquires Badby from Patron
BC Partners bought 22 mental health facilities in the UK, formerly part of Priory Group, in November
Cinven backed Synlab raises €250m via capital increase
Cinven will remain the majority shareholder of Synlab and other LP will retain its current stake
Deal in Focus: Bain and Cinven to take Stada private
Acquisition of German pharmaceutical company would be the largest buyout ever recorded in the country